Lista de obras -

A proof of concept for the detection and classification of pulmonary arterial hypertension through breath analysis with a sensor array

artículo científico publicado en 2013

Abnormal Immunoregulation Involving the IL-2/IL-2 Receptor Complex in Myasthenia Gravis

scientific article published on 01 June 1993

Altered intrathymic T-cell repertoire in human myasthenia gravis

artículo científico publicado en 1997

Antibodies to thymic epithelial cells in myasthenia gravis

artículo científico publicado en 1991

Autoimmunity And Pulmonary Arterial Hypertension: The Role Of Leptin

C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension.

artículo científico publicado en 2011

CXCL13 in tertiary lymphoid tissues: sites of production are different from sites of functional localization

artículo científico publicado en 2014

Cellular aspects of myasthenia gravis

article

Chemotherapy-induced pulmonary hypertension: role of alkylating agents.

artículo científico publicado en 2014

Chromatin immunoselection defines a TAL-1 target gene

artículo científico publicado en 1998

Circulating fibrocytes and pulmonary arterial hypertension

artículo científico publicado en 2012

Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis

artículo científico publicado en 2003

Convergent Strategy to Dizocilpine MK-801 and Derivatives

artículo científico publicado en 2018

Cytotoxic Cells and Granulysin in Pulmonary Arterial Hypertension and Pulmonary Veno-occlusive Disease

artículo científico publicado en 2012

Detecting lung infections in breathprints: empty promise or next generation diagnosis of infections

artículo científico publicado en 2015

Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules

artículo científico publicado en 2017

Does Circulating IL-17 Identify a Subset of Patients With Idiopathic Pulmonary Arterial Hypertension?: Response

artículo científico publicado en 2015

Endothelial-to-mesenchymal transition in pulmonary hypertension.

artículo científico publicado en 2015

Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath

artículo científico

Evidence of enhanced recombinant interleukin-2 sensitivity in thymic lymphocytes from patients with myasthenia gravis: possible role in autoimmune pathogenesis

artículo científico publicado en 1989

Follow-up of soluble interleukin-2 receptor levels after thymectomy in patients with myasthenia gravis

artículo científico publicado en 1992

Functional interaction between PDGFβ and GluN2B-containing NMDA receptors in smooth muscle cell proliferation and migration in pulmonary arterial hypertension

scientific article published on 13 December 2018

Half of the T-cell repertoire combinatorial diversity is genetically determined in humans and humanized mice.

artículo científico publicado en 2011

High IL-6 Gene Expression and Production by Cultured Human Thymic Epithelial Cells from Patients with Myasthenia Gravis

article

High recombinant interleukin-2 sensitivity of peripheral blood lymphocytes from patients with myasthenia gravis: correlations with clinical parameters

How does binding of agonist ligands control intrinsic molecular dynamics in human NMDA receptors?

artículo científico publicado en 2018

Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis

artículo científico publicado en 1993

Imatinib inhibits bone marrow-derived c-kit+ cell mobilisation in hypoxic pulmonary hypertension.

artículo científico publicado en 2010

Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay

artículo científico

Implication of the deacetylase sirtuin-1 on synovial angiogenesis and persistence of experimental arthritis

artículo científico publicado en 2020

In Situ Production of Interleukins in Hyperplastic Thymus from Myasthenia Gravis Patients

artículo científico publicado en 1993

In situ production of interleukins in hyperplastic thymus from myasthenia gravis patients

article

In vitro interleukin-1 (IL-1) production in thymic hyperplasia and thymoma from patients with myasthenia gravis

artículo científico publicado en 1991

In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression

artículo científico publicado en 2020

In vivo preferential usage of TCR V/gb8 in Torpedo acetylcholine receptor immune response in the murine experimental model of myasthenia gravis

article

Inflammation in Pulmonary Arterial Hypertension

artículo científico publicado en 2012

Inflammation in pulmonary hypertension: what we know and what we could logically and safely target first.

artículo científico publicado en 2014

Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension

artículo científico publicado en 2012

MicroRNA networks in pulmonary arterial hypertension: share mechanisms with cancer?

artículo científico publicado en 2015

Monoclonal antibody against the lupus antigen Sm cross-reacts with RNA polymerase I.

artículo científico publicado en 1989

Multimodal Imaging Mass Spectrometry to Identify Markers of Pulmonary Arterial Hypertension in Human Lung Tissue using MALDI-ToF, ToF-SIMS and Hybrid SIMS

artículo científico publicado en 2020

N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats

artículo científico publicado en 2014

NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.

artículo científico publicado en 2018

Nouvelles approches immunopathologiques de l’hypertension artérielle pulmonaire

scientific article published on 01 April 2011

On-chip hybridization kinetics for optimization of gene expression experiments

artículo científico publicado en 2008

Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis

artículo científico publicado en 1999

Proliferative Responses to Acetylcholine Receptor Peptides in Myasthenia Gravis

article

Prospects for a T-cell receptor vaccination against myasthenia gravis

artículo científico publicado en 2005

Pulmonary arterial hypertension: a flavor of autoimmunity

artículo científico publicado en 2013

Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension

artículo científico publicado en 2011

Rationale for a T Cell Receptor Peptide Therapy in Myasthenia Gravis

artículo científico publicado en 2003

Reproducibility, interrater agreement, and age-related changes of fractional anisotropy measures at 3T in healthy subjects: effect of the applied b-value

artículo científico publicado en 2008

Respective role of thymus and muscle in autoimmune myasthenia gravis

artículo científico publicado en 1998

Responsiveness of Myasthenia Gravis Lymphocytes to Recombinant Interleukin-2

artículo científico publicado en 1988

Sustained calcium signalling and caspase-3 activation involve NMDA receptors in thymocytes in contact with dendritic cells.

artículo científico publicado en 2010

Synergistic induction of interleukin-6 production and gene expression in human thymic epithelial cells by LPS and cytokines

artículo científico publicado en 1991

T-Cell Receptor Expression in the Thymus from Patients with Myasthenia Gravis

artículo científico publicado en 1995

T-cell antigenic sites involved in Myasthenia Gravis: Correlations with antibody titre and disease severity

scientific article published on 01 February 1991

T-helper 17 cell polarization in pulmonary arterial hypertension

artículo científico publicado en 2015

Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension.

artículo científico publicado en 2010

The cancer paradigm in pulmonary arterial hypertension: towards anti-remodeling therapies targeting metabolic dysfunction?

artículo científico publicado en 2016

Understanding the Role of CD4+CD25 high (So-Called Regulatory) T Cells in Idiopathic Pulmonary Arterial Hypertension

artículo científico publicado en 2008

Volatolomics of breath as an emerging frontier in pulmonary arterial hypertension

artículo científico publicado en 2017

p45 NF-E2 regulates expression of thromboxane synthase in megakaryocytes

artículo científico publicado en 1997

Lista de obras de

A proof of concept for the detection and classification of pulmonary arterial hypertension through breath analysis with a sensor array

Abnormal Immunoregulation Involving the IL-2/IL-2 Receptor Complex in Myasthenia Gravis

Altered intrathymic T-cell repertoire in human myasthenia gravis

Antibodies to thymic epithelial cells in myasthenia gravis

Autoimmunity And Pulmonary Arterial Hypertension: The Role Of Leptin

C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension.

CXCL13 in tertiary lymphoid tissues: sites of production are different from sites of functional localization

Cellular aspects of myasthenia gravis

Chemotherapy-induced pulmonary hypertension: role of alkylating agents.

Chromatin immunoselection defines a TAL-1 target gene

Circulating fibrocytes and pulmonary arterial hypertension

Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis

Convergent Strategy to Dizocilpine MK-801 and Derivatives

Cytotoxic Cells and Granulysin in Pulmonary Arterial Hypertension and Pulmonary Veno-occlusive Disease

Detecting lung infections in breathprints: empty promise or next generation diagnosis of infections

Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules

Does Circulating IL-17 Identify a Subset of Patients With Idiopathic Pulmonary Arterial Hypertension?: Response

Endothelial-to-mesenchymal transition in pulmonary hypertension.

Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath

Evidence of enhanced recombinant interleukin-2 sensitivity in thymic lymphocytes from patients with myasthenia gravis: possible role in autoimmune pathogenesis

Follow-up of soluble interleukin-2 receptor levels after thymectomy in patients with myasthenia gravis

Functional interaction between PDGFβ and GluN2B-containing NMDA receptors in smooth muscle cell proliferation and migration in pulmonary arterial hypertension

Half of the T-cell repertoire combinatorial diversity is genetically determined in humans and humanized mice.

High IL-6 Gene Expression and Production by Cultured Human Thymic Epithelial Cells from Patients with Myasthenia Gravis

High recombinant interleukin-2 sensitivity of peripheral blood lymphocytes from patients with myasthenia gravis: correlations with clinical parameters

How does binding of agonist ligands control intrinsic molecular dynamics in human NMDA receptors?

Identification by genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis

Imatinib inhibits bone marrow-derived c-kit+ cell mobilisation in hypoxic pulmonary hypertension.

Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay

Implication of the deacetylase sirtuin-1 on synovial angiogenesis and persistence of experimental arthritis

In Situ Production of Interleukins in Hyperplastic Thymus from Myasthenia Gravis Patients

In situ production of interleukins in hyperplastic thymus from myasthenia gravis patients

In vitro interleukin-1 (IL-1) production in thymic hyperplasia and thymoma from patients with myasthenia gravis

In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression

In vivo preferential usage of TCR V/gb8 in Torpedo acetylcholine receptor immune response in the murine experimental model of myasthenia gravis

Inflammation in Pulmonary Arterial Hypertension

Inflammation in pulmonary hypertension: what we know and what we could logically and safely target first.

Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension

MicroRNA networks in pulmonary arterial hypertension: share mechanisms with cancer?

Monoclonal antibody against the lupus antigen Sm cross-reacts with RNA polymerase I.

Multimodal Imaging Mass Spectrometry to Identify Markers of Pulmonary Arterial Hypertension in Human Lung Tissue using MALDI-ToF, ToF-SIMS and Hybrid SIMS

N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats

NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.

Nouvelles approches immunopathologiques de l’hypertension artérielle pulmonaire

On-chip hybridization kinetics for optimization of gene expression experiments

Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis

Proliferative Responses to Acetylcholine Receptor Peptides in Myasthenia Gravis

Prospects for a T-cell receptor vaccination against myasthenia gravis

Pulmonary arterial hypertension: a flavor of autoimmunity

Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension

Rationale for a T Cell Receptor Peptide Therapy in Myasthenia Gravis

Reproducibility, interrater agreement, and age-related changes of fractional anisotropy measures at 3T in healthy subjects: effect of the applied b-value

Respective role of thymus and muscle in autoimmune myasthenia gravis

Responsiveness of Myasthenia Gravis Lymphocytes to Recombinant Interleukin-2

Sustained calcium signalling and caspase-3 activation involve NMDA receptors in thymocytes in contact with dendritic cells.

Synergistic induction of interleukin-6 production and gene expression in human thymic epithelial cells by LPS and cytokines

T-Cell Receptor Expression in the Thymus from Patients with Myasthenia Gravis

T-cell antigenic sites involved in Myasthenia Gravis: Correlations with antibody titre and disease severity

T-helper 17 cell polarization in pulmonary arterial hypertension

Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension.

The cancer paradigm in pulmonary arterial hypertension: towards anti-remodeling therapies targeting metabolic dysfunction?

Understanding the Role of CD4+CD25 high (So-Called Regulatory) T Cells in Idiopathic Pulmonary Arterial Hypertension

Volatolomics of breath as an emerging frontier in pulmonary arterial hypertension

p45 NF-E2 regulates expression of thromboxane synthase in megakaryocytes